Sidley Austin is representing Nektar Therapeutics in the transaction, and Goodwin Procter is representing Ampersand Capital Partners.Ampersand has agreed to acquire Nektar’s commercial-scale manufacturing facility and…
Ampersand’s Acquisition of a Nektar’s Manufacturing Facility and Reagent Supply Business
